Risk of drug-induced agranulocytosis: The case of calcium dobesilate

European Journal of Clinical Pharmacology

Volumn 58, Issue 11, 2003, Pages 767-772

  Zapater, Pedro ^a   Francisco Horga, José ^a   García, Antonio ^b,c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Agranulocytosis; Calcium dobesilate; Case control study

Indexed keywords

DOBESILATE CALCIUM;

AGE; AGRANULOCYTOSIS; ARTICLE; CALCULATION; CASE CONTROL STUDY; CHRONIC VEIN INSUFFICIENCY; DIABETIC RETINOPATHY; DRUG INDUCED DISEASE; HUMAN; INCIDENCE; POISSON DISTRIBUTION; PRIORITY JOURNAL; RISK; SPAIN; TIME;

EID: 0037354374     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0550-6     Document Type: Article

References (10)

1. Patton WN, Duffull SB (1994) Idiosyncratic drug-induced haematological abnormalities. Drug Saf 11:445-462
2. The International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749-1757
3. Keisu M, Ekman E, Wiholm BE (1992) Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control study. Eur J Clin Pharmacol 43:211-214
4. Fletcher AP (1991) Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med 14:341-344
5. Ibañez L, Ballarin E, Vidal X, Laporte JR (2000) Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches. Eur J Clin Pharmacol 56:763-767
6. Begaud B, Moride Y, Turbert-Bitter P, Chaslerie A, Haramburu F (1994) False-positives in spontaneous reporting: should we worry about them? Br J Clin Pharmacol 38:401-404
7. Tubert P, Bégaud B, Péré JC, Haramburu F, Lellouch J (1992) Power and weakness of spontaneous reporting: a probabilitistic approach. J Clin Epidemiol 45:283-286
8. Cladera Serra A, Blasco Mascaro I, Oliva Berini E, Ramos Diaz F (1995) Agranulocytosis induced by calcium dobesilate. Med Clin (Barc) 105:558-559
9. Garcia Benayas E, Garcia Diaz B, Perez G (1997) Calcium dobesilate-induced agranulocytosis. Pharm World Sci 19:251-252
10. Azaceta G, Sáenz-Cusi A, Olave T, Palomera L (2000) Agranulocitosis inducida por dobesilato cálcico: a propósito de un nuevo caso. An Med Interna 17:337-338